基本信息
浏览量:316
职业迁徙
个人简介
Together with my colleagues in the Genetic Pathology Evaluation Center, we have taken advantage of the excellent patient outcome data available through the British Columbia Cancer Agency to create tissue microarrays (TMAs) that have allowed for examination of large numbers of cases of breast cancer, ovarian cancer, endometrial cancer and other cancer types, correlating immunostaining and FISH results with patient outcomes.
Starting with a presentation to the International Society of Gynecological Pathology annual meeting, and subsequently published in the society journal as a review article (Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol. 2004;23:200-5), I have advanced the hypothesis that ovarian cancer subtypes, recognizable based on histopathological examination, are distinct diseases, with different risk factors, genetic events during oncogenesis, precursor lesions, natural history, and response to chemotherapy. We founded a local ovarian carcinoma research group, OvCaRe, and have shown that these subtypes can be reproducibly diagnosed by surgical pathologists and are studying the subtype specific molecular abnormalities in these tumors. This has been my primary academic focus for the past 5 years. This is a subject of clinical import as we move towards subtype specific treatment of ovarian carcinoma. More recently the gynecological cancer focus has expanded to include uterine and vulvar cancers.
Starting with a presentation to the International Society of Gynecological Pathology annual meeting, and subsequently published in the society journal as a review article (Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol. 2004;23:200-5), I have advanced the hypothesis that ovarian cancer subtypes, recognizable based on histopathological examination, are distinct diseases, with different risk factors, genetic events during oncogenesis, precursor lesions, natural history, and response to chemotherapy. We founded a local ovarian carcinoma research group, OvCaRe, and have shown that these subtypes can be reproducibly diagnosed by surgical pathologists and are studying the subtype specific molecular abnormalities in these tumors. This has been my primary academic focus for the past 5 years. This is a subject of clinical import as we move towards subtype specific treatment of ovarian carcinoma. More recently the gynecological cancer focus has expanded to include uterine and vulvar cancers.
研究兴趣
论文共 935 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Modern Pathologyno. 2 (2024): 100417-100417
JOURNAL OF PATHOLOGYno. 1 (2024): 4-9
AMERICAN JOURNAL OF SURGICAL PATHOLOGYno. 3 (2024): 373-373
medRxiv (Cold Spring Harbor Laboratory) (2023)
Melissa K. McConechy,Amy Jamieson,Amy Lum,Samuel Leung, Adrian Kense,Sonal Brahmbhatt,Ka Mun Nip, Ebru Baran, D. S. Perera, Kurt M. Yakimovich,Ruth A. Miller,C. Blake Gilks,
Cancer Researchno. 7_Supplement (2023): 4542-4542
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn